Holland & Knight’s Michael Werner talks to Dr. Russell Medford, President and CEO of Salutria Pharmaceuticals, a privately-held biotech company based in Alpharetta Georgia. Dr. Medford is also co-chair of BIO’s Board Standing Committee on Bioethics. Dr. Medford will be providing testimony on Wednesday November 16 to the Presidential Commission for the Study of Bioethical Issues on Principles Regarding Ethical Performance of International Clinical Trials.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsbiotechnology health USPTO Food agriculture biofuel climate change Plant biotechnology Intellectual Property GMOs BIO EVENT BIO International Convention biotech industry Animal biotechnology Sustainability Health Care Benefits of biotech crops Industry Analysis global food crisis BIOTECH
- Most Popular